MOLOGEN AG / Key word(s): Capital Increase 22.04.2015 19:13 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- MOLOGEN AG successfully closes capital increase from authorized capital; gross proceeds of EUR 28.29 million Berlin, April 22, 2015 - MOLOGEN AG (ISIN DE0006637200/WKN 663720) successfully placed new shares from the cash capital increase resolved on 24 March 2015 with indirect subscription rights of the existing shareholders and subsequent international private placement with qualified investors in the full amount of 5,657,875 shares (corresponds to 33.33 % of the currently existing share capital). The purchase price in the context of the private placement was fixed at EUR 5.00 per new share and thus corresponds to the subscription price for existing shareholders. The share capital will therefore be increased, through the issuance of 5,657,875 new bearer shares with no par value, from currently EUR 16,973,626.00 to then EUR 22,631,501.00. The gross proceeds from the share issuance amount to approximately EUR 28.29 million. The management board will shortly apply for the registration of the implementation of the capital increases with the commercial register. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: DISCLAIMER This announcement does not constitute an offer to buy shares or other securities of MOLOGEN AG and does not replace the prospectus. Investment decisions with respect to the shares or other securities of MOLOGEN AG shall only take place on the basis of the prospectus which will be available after the approval by the German Financial Supervisory Authority (BaFin) free of charge at MOLOGEN AG. This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in the United States of America (the 'United States'), Australia, Canada or Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to in this announcement will not be and have not been registered under the U.S. Securities Act of 1933, as amended (the 'U.S. Securities Act') and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements under the U.S. Securities Act. Subject to certain exceptions, the securities referred to in this announcement may not be offered or sold in Australia, Canada or Japan, or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. The offer and sale of the securities referred to in this announcement has not been and will not be registered under the U.S. Securities Act or under the applicable securities laws of Australia, Canada or Japan. There will be no public offer of the securities in the United States. Contact Claudia Nickolaus Head of Investor Relations & Corporate Communications Tel: +49 - 30 - 84 17 88 - 38 Fax: +49 - 30 - 84 17 88 - 50 investor@mologen.com 22.04.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: MOLOGEN AG FabeckstraÃe 30 14195 Berlin Germany Phone: 030 / 841788-0 Fax: 030 / 841788-50 E-mail: presse@mologen.com Internet: www.mologen.com ISIN: DE0006637200 WKN: 663720 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: MOLOGEN AG successfully closes capital increase from authorized capital; gross proceeds of EUR 28.29 million
| Source: EQS Group AG